LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 3 von insgesamt 3

Suchoptionen

  1. Artikel ; Online: Pharmacological targeting of host chaperones protects from pertussis toxin in vitro and in vivo

    Katharina Ernst / Ann-Katrin Mittler / Veronika Winkelmann / Carolin Kling / Nina Eberhardt / Anna Anastasia / Michael Sonnabend / Robin Lochbaum / Jan Wirsching / Moona Sakari / Arto T. Pulliainen / Ciaran Skerry / Nicholas H. Carbonetti / Manfred Frick / Holger Barth

    Scientific Reports, Vol 11, Iss 1, Pp 1-

    2021  Band 17

    Abstract: Abstract Whooping cough is caused by Bordetella pertussis that releases pertussis toxin (PT) which comprises enzyme A-subunit PTS1 and binding/transport B-subunit. After receptor-mediated endocytosis, PT reaches the endoplasmic reticulum from where ... ...

    Abstract Abstract Whooping cough is caused by Bordetella pertussis that releases pertussis toxin (PT) which comprises enzyme A-subunit PTS1 and binding/transport B-subunit. After receptor-mediated endocytosis, PT reaches the endoplasmic reticulum from where unfolded PTS1 is transported to the cytosol. PTS1 ADP-ribosylates G-protein α-subunits resulting in increased cAMP signaling. Here, a role of target cell chaperones Hsp90, Hsp70, cyclophilins and FK506-binding proteins for cytosolic PTS1-uptake is demonstrated. PTS1 specifically and directly interacts with chaperones in vitro and in cells. Specific pharmacological chaperone inhibition protects CHO-K1, human primary airway basal cells and a fully differentiated airway epithelium from PT-intoxication by reducing intracellular PTS1-amounts without affecting cell binding or enzyme activity. PT is internalized by human airway epithelium secretory but not ciliated cells and leads to increase of apical surface liquid. Cyclophilin-inhibitors reduced leukocytosis in infant mouse model of pertussis, indicating their promising potential for developing novel therapeutic strategies against whooping cough.
    Schlagwörter Medicine ; R ; Science ; Q
    Sprache Englisch
    Erscheinungsdatum 2021-03-01T00:00:00Z
    Verlag Nature Portfolio
    Dokumenttyp Artikel ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Volltext online

    Zusatzmaterialien

    Kategorien

    Fernleihe an ZB MED

    Sie können sich den gewünschten Titel als lokale Nutzerin oder lokaler Nutzer von ZB MED direkt an den Standort Köln schicken lassen.

  2. Artikel ; Online: IL-13 Impairs Tight Junctions in Airway Epithelia

    Hanna Schmidt / Peter Braubach / Carolin Schilpp / Robin Lochbaum / Kathrin Neuland / Kristin Thompson / Danny Jonigk / Manfred Frick / Paul Dietl / Oliver H. Wittekindt

    International Journal of Molecular Sciences, Vol 20, Iss 13, p

    2019  Band 3222

    Abstract: Interleukin-13 (IL-13) drives symptoms in asthma with high levels of T-helper type 2 cells (T h 2-cells). Since tight junctions (TJ) constitute the epithelial diffusion barrier, we investigated the effect of IL-13 on TJ in human tracheal epithelial cells. ...

    Abstract Interleukin-13 (IL-13) drives symptoms in asthma with high levels of T-helper type 2 cells (T h 2-cells). Since tight junctions (TJ) constitute the epithelial diffusion barrier, we investigated the effect of IL-13 on TJ in human tracheal epithelial cells. We observed that IL-13 increases paracellular permeability, changes claudin expression pattern and induces intracellular aggregation of the TJ proteins zonlua occludens protein 1, as well as claudins. Furthermore, IL-13 treatment increases expression of ubiquitin conjugating E2 enzyme UBE2Z. Co-localization and proximity ligation assays further showed that ubiquitin and the proteasomal marker PSMA5 co-localize with TJ proteins in IL-13 treated cells, showing that TJ proteins are ubiquitinated following IL-13 exposure. UBE2Z upregulation occurs within the first day after IL-13 exposure. Proteasomal aggregation of ubiquitinated TJ proteins starts three days after IL-13 exposure and transepithelial electrical resistance (TEER) decrease follows the time course of TJ-protein aggregation. Inhibition of JAK/STAT signaling abolishes IL-13 induced effects. Our data suggest that that IL-13 induces ubiquitination and proteasomal aggregation of TJ proteins via JAK/STAT dependent expression of UBE2Z, resulting in opening of TJs. This may contribute to barrier disturbances in pulmonary epithelia and lung damage of patients with inflammatory lung diseases.
    Schlagwörter lung ; epithelia ; interleukin 13 ; tight junction ; UBE2Z ; ubiquitin ; Biology (General) ; QH301-705.5 ; Chemistry ; QD1-999
    Sprache Englisch
    Erscheinungsdatum 2019-06-01T00:00:00Z
    Verlag MDPI AG
    Dokumenttyp Artikel ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Volltext online

    Zusatzmaterialien

    Kategorien

    Fernleihe an ZB MED

    Sie können sich den gewünschten Titel als lokale Nutzerin oder lokaler Nutzer von ZB MED direkt an den Standort Köln schicken lassen.

  3. Artikel ; Online: Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection

    Lukas Wettstein / Tatjana Weil / Carina Conzelmann / Janis A. Müller / Rüdiger Groß / Maximilian Hirschenberger / Alina Seidel / Susanne Klute / Fabian Zech / Caterina Prelli Bozzo / Nico Preising / Giorgio Fois / Robin Lochbaum / Philip Maximilian Knaff / Volker Mailänder / Ludger Ständker / Dietmar Rudolf Thal / Christian Schumann / Steffen Stenger /
    Alexander Kleger / Günter Lochnit / Benjamin Mayer / Yasser B. Ruiz-Blanco / Markus Hoffmann / Konstantin M. J. Sparrer / Stefan Pöhlmann / Elsa Sanchez-Garcia / Frank Kirchhoff / Manfred Frick / Jan Münch

    Nature Communications, Vol 12, Iss 1, Pp 1-

    2021  Band 10

    Abstract: Here, via screening of a polypeptide library from bronchoalveolar lavage, the authors identify and characterize α1-antitrypsin (α1AT) as SARS-CoV-2 inhibitor and show that α1AT binds and inactivates the serine protease TMPRSS2, which enzymatically primes ...

    Abstract Here, via screening of a polypeptide library from bronchoalveolar lavage, the authors identify and characterize α1-antitrypsin (α1AT) as SARS-CoV-2 inhibitor and show that α1AT binds and inactivates the serine protease TMPRSS2, which enzymatically primes the SARS-CoV-2 spike protein for membrane fusion.
    Schlagwörter Science ; Q
    Sprache Englisch
    Erscheinungsdatum 2021-03-01T00:00:00Z
    Verlag Nature Portfolio
    Dokumenttyp Artikel ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Volltext online

    Zusatzmaterialien

    Kategorien

    Fernleihe an ZB MED

    Sie können sich den gewünschten Titel als lokale Nutzerin oder lokaler Nutzer von ZB MED direkt an den Standort Köln schicken lassen.

Zum Seitenanfang